Lv1
20 积分 2024-03-15 加入
Prognostic Value of the Gustave Roussy Immune Score in Lung Cancer: A Meta-Analysis
6小时前
待确认
Immunogenomic correlates of immune-related adverse events for anti–programmed cell death 1 therapy
3个月前
已完结
Therapeutic efficacy analysis of immunotherapy in small cell lung cancer
3个月前
已完结
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
4个月前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
4个月前
已完结
Peripheral B-cell levels predict efficacy and overall survival in advanced melanoma patients under PD-1 immunotherapy
4个月前
已完结
Participation of B cell in immunotherapy of cancer
4个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
5个月前
已完结
Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202)
5个月前
已完结
MHC class II expression in lung cancer
5个月前
已完结
皖公网安备34019202002308
